Venezuelan equine encephalitis virus: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''Venezuelan equine encephalitis virus''' | {{Short description|Virus causing Venezuelan equine encephalitis}} | ||
{{Taxobox | |||
| name = Venezuelan equine encephalitis virus | |||
| virus_group = iv | |||
| ordo = [[Togavirales]] | |||
| familia = [[Togaviridae]] | |||
| genus = [[Alphavirus]] | |||
| species = '''Venezuelan equine encephalitis virus''' | |||
}} | |||
[[File:Venezuelan_equine_encephalitis_virus.jpg|thumb|right|Electron micrograph of Venezuelan equine encephalitis virus]] | |||
'''Venezuelan equine encephalitis virus''' (VEEV) is a [[virus]] that belongs to the [[genus]] [[Alphavirus]] in the [[family]] [[Togaviridae]]. It is the causative agent of [[Venezuelan equine encephalitis]], a disease that affects both [[equids]] and humans. | |||
==Virology== | |||
VEEV is an [[enveloped virus]] with a single-stranded, positive-sense [[RNA]] genome. The virus is primarily transmitted by [[mosquitoes]], which act as vectors. The [[genome]] of VEEV encodes non-structural proteins involved in [[viral replication]] and structural proteins that form the [[viral particle]]. | |||
==Transmission== | |||
The virus is transmitted to [[equids]] and humans through the bite of infected mosquitoes, primarily of the [[Culex]] and [[Aedes]] genera. In equids, the virus can cause severe [[neurological]] disease, while in humans, it can lead to [[flu-like symptoms]] and, in severe cases, [[encephalitis]]. | |||
==Epidemiology== | ==Epidemiology== | ||
VEEV is | VEEV is endemic in regions of [[Central America]] and [[South America]], particularly in [[Venezuela]], where outbreaks have been recorded. The virus can cause significant [[morbidity]] and [[mortality]] in equine populations, and human cases are often associated with these outbreaks. | ||
==Clinical | ==Clinical Features== | ||
In | In equids, VEEV infection can lead to fever, depression, and neurological signs such as ataxia and seizures. In humans, symptoms range from mild flu-like illness to severe [[encephalitis]], which can result in [[coma]] or death. | ||
==Prevention and Control== | ==Prevention and Control== | ||
Control measures include vaccination of equids and mosquito control programs to reduce the risk of transmission. Vaccines for humans are under development but are not widely available. | |||
==Research== | |||
Research on VEEV focuses on understanding its [[pathogenesis]], developing effective vaccines, and improving diagnostic methods. The virus is also studied as a potential [[biological weapon]] due to its ability to cause widespread disease. | |||
== | ==Related pages== | ||
* [[Alphavirus]] | |||
* [[Togaviridae]] | |||
* [[Encephalitis]] | |||
== | ==References== | ||
* | * Weaver, S. C., & Barrett, A. D. (2004). Transmission cycles, host range, evolution and emergence of arboviral disease. Nature Reviews Microbiology, 2(10), 789-801. | ||
* | * Griffin, D. E. (2001). Alphaviruses. In Fields Virology (4th ed., pp. 917-962). Lippincott Williams & Wilkins. | ||
[[Category: | [[Category:Alphaviruses]] | ||
[[Category: | [[Category:Animal viral diseases]] | ||
[[Category: | [[Category:Zoonoses]] | ||
Revision as of 16:15, 9 February 2025
Virus causing Venezuelan equine encephalitis
Venezuelan equine encephalitis virus (VEEV) is a virus that belongs to the genus Alphavirus in the family Togaviridae. It is the causative agent of Venezuelan equine encephalitis, a disease that affects both equids and humans.
Virology
VEEV is an enveloped virus with a single-stranded, positive-sense RNA genome. The virus is primarily transmitted by mosquitoes, which act as vectors. The genome of VEEV encodes non-structural proteins involved in viral replication and structural proteins that form the viral particle.
Transmission
The virus is transmitted to equids and humans through the bite of infected mosquitoes, primarily of the Culex and Aedes genera. In equids, the virus can cause severe neurological disease, while in humans, it can lead to flu-like symptoms and, in severe cases, encephalitis.
Epidemiology
VEEV is endemic in regions of Central America and South America, particularly in Venezuela, where outbreaks have been recorded. The virus can cause significant morbidity and mortality in equine populations, and human cases are often associated with these outbreaks.
Clinical Features
In equids, VEEV infection can lead to fever, depression, and neurological signs such as ataxia and seizures. In humans, symptoms range from mild flu-like illness to severe encephalitis, which can result in coma or death.
Prevention and Control
Control measures include vaccination of equids and mosquito control programs to reduce the risk of transmission. Vaccines for humans are under development but are not widely available.
Research
Research on VEEV focuses on understanding its pathogenesis, developing effective vaccines, and improving diagnostic methods. The virus is also studied as a potential biological weapon due to its ability to cause widespread disease.
Related pages
References
- Weaver, S. C., & Barrett, A. D. (2004). Transmission cycles, host range, evolution and emergence of arboviral disease. Nature Reviews Microbiology, 2(10), 789-801.
- Griffin, D. E. (2001). Alphaviruses. In Fields Virology (4th ed., pp. 917-962). Lippincott Williams & Wilkins.
